Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Top Cited Papers
- 5 September 2024
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 18 (5) , e647-e663
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without AtherosclerosisJAMA Cardiology, 2021
- Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride LevelsJAMA Network Open, 2021
- A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or HypertriglyceridemiaJAMA Cardiology, 2020
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart DiseaseJAMA, 2019
- Genetic Studies Help Clarify the Complexities of Lipid Biology and TreatmentJAMA, 2017
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular RiskJAMA, 2017
- Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid ProfileJAMA, 2013
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With StatinsJAMA, 2012
- Blood Lipid MeasurementsJAMA, 1992
- A Comparison of Methods for the Estimation of Plasma Low- and Very Low-Density Lipoprotein CholesterolJAMA, 1986